• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
UCM 0.00% 3.2¢

USCOM LIMITED - Announcements

Uscom Limited is a medical technology company. It specializes in the development and... Uscom Limited is a medical technology company. It specializes in the development and marketing of non-invasive cardiovascular and pulmonary medical devices. It has three suites of devices in the field of cardiac, vascular, and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities, and is used to guide treatment. The USCOM 1A device has applications in emergency, intensive care medicine and anesthesia. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms in the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. Its VENTITEST digital ultrasonic ventilator testing solution is a new system for testing ventilators.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

UCM Uscom Earnings Call19/02/15
UCM Appendix 4C - quarterlyPRICE SENSITIVE29/01/15
UCM USCOM 1A - New Regulatory Registration for ChinaPRICE SENSITIVE27/01/15
UCM Distribution and Sales Manager Appointment17/12/14
UCM Appendix 3B03/12/14
UCM Change of Director's Interest Notice Appendix 3Y27/11/14
UCM Appendix 3B27/11/14
UCM Results of Meeting26/11/14
UCM 2014 AGM Presentation26/11/14
UCM Uscom - Johnson and Johnson Innovation Company of the Year30/10/14
UCM USCOM Sale into Space Programme27/10/14
UCM Notice of Annual General Meeting/Proxy Form24/10/14
UCM Appendix 4C - quarterlyPRICE SENSITIVE21/10/14
UCM Appendix 3B09/10/14
UCM Appendix 3B01/10/14
UCM Date of AGM29/09/14
UCM Uscom Finalist in NSW Premiers Export Awards17/09/14
UCM USCOM Part of World Sepsis Day in London12/09/14
UCM Uscom Presentation09/09/14
UCM New USCOM science in critical applicationsPRICE SENSITIVE04/09/14
UCM TGA Approval for Uscom BP Central Blood PressurePRICE SENSITIVE25/08/14
UCM Preliminary and Annual Report to shareholdersPRICE SENSITIVE18/08/14
UCM Appendix 4C - quarterlyPRICE SENSITIVE28/07/14
UCM Uscom Manufactures First Australian BPplus DevicePRICE SENSITIVE23/06/14
UCM Release of securities from voluntary escrow20/06/14
UCM Uscom appoints new US distributor for USCOM 1A monitorPRICE SENSITIVE16/06/14
UCM Change in substantial holding10/06/14
UCMChange in substantial holding29/05/14
UCMChange in substantial holding23/05/14
UCMAppendix 3B20/05/14
UCMUscom Limited Securities Issued Under Listing Rule 7.1A20/05/14
UCMCleansing Statement - Private Placement20/05/14
UCMUscom appoints three new UK distributors for BP monitorPRICE SENSITIVE19/05/14
UCMUscom Announces Successful Capital RaisingPRICE SENSITIVE15/05/14
UCMTrading HaltPRICE SENSITIVE13/05/14
UCMUscom receives new US Patent notification for BP monitorPRICE SENSITIVE12/05/14
UCMAppendix 4C - quarterlyPRICE SENSITIVE28/04/14
UCMInvestment overview27/03/14
UCMUscom appoints new Scandinavian distributor10/03/14
UCMUscom appoints new German distributor03/03/14
UCMChange of Director's Interest Notice28/02/14
UCMAppendix 3B28/02/14
UCMUscom appoints new European distributorPRICE SENSITIVE27/02/14
UCMUscom BP new hypertension gold standard in childrenPRICE SENSITIVE24/02/14
UCMHalf Yearly Report and AccountsPRICE SENSITIVE21/02/14
UCMUscom Presentation20/02/14
UCMUscom BP leading blood pressure technology - Global studyPRICE SENSITIVE10/02/14
UCMUscom BP receives CE Mark for sales into EuropePRICE SENSITIVE04/02/14
UCMUscom appoints Deltex to distribution teamPRICE SENSITIVE29/01/14
UCMAppendix 4C - quarterlyPRICE SENSITIVE29/01/14
UCMChange in substantial holding20/12/13
UCMChange of Director's Interest Notice14/11/13
UCMCleansing Notice14/11/13
UCMAppendix 3B14/11/13
UCMResults of Meeting13/11/13
UCM2013 AGM Presentation13/11/13
UCMNew US USCOM Distribution Agreement12/11/13
UCMAppendix 4C - quarterlyPRICE SENSITIVE28/10/13
UCMUscom signs 5 year $7m China sales dealPRICE SENSITIVE15/10/13
UCMNotice of Annual General Meeting/Proxy Form11/10/13
UCMUscom - New Global Sales Manager Appointed24/09/13
UCMAppendix 3B18/09/13
UCMSecurities Issued Under Listing Rule 7.1A18/09/13
UCMCleansing Notice18/09/13
UCMSuccessful capital raising to support new sales initiativesPRICE SENSITIVE18/09/13
UCMPreliminary and Annual Report to shareholdersPRICE SENSITIVE30/08/13
UCMUscom Presentation - Amended07/08/13
UCMUscom Presentation07/08/13
UCMCleansing Notice06/08/13
UCMAppendix 3B06/08/13
UCMAppendix 4C - quarterlyPRICE SENSITIVE26/07/13
UCMCompany Secretary Appointment/Resignation18/07/13
UCMUSCOM - New Paediatric Publications in Sepsis and Emergency03/07/13
UCMUscom Announces Italian Distribution Deal with VegaPRICE SENSITIVE25/06/13
UCMCleansing Notice20/06/13
UCMUscom Completes Pulsecor Asset Purchase - Amended Date18/06/13
UCMUscom Completes Pulsecor Asset PurchasePRICE SENSITIVE18/06/13
UCMAppendix 3B17/06/13
UCMUscom Presentation - Amended17/06/13
UCMUscom Presentation14/06/13
UCMUscom to Acquire Pulsecor and New Blood Pressure ProductsPRICE SENSITIVE30/05/13
UCMChange of Director's Interest Notice16/05/13
UCMNew USCOM Method for Measurement of Heart FunctionPRICE SENSITIVE08/05/13
UCMUSCOM Strategic Focus - New Distribution in MexicoPRICE SENSITIVE01/05/13
UCMAppendix 4C - quarterlyPRICE SENSITIVE26/04/13
UCMChange of Director's Interest Notice19/03/13
UCMHalf Yearly Report and AccountsPRICE SENSITIVE27/02/13
UCMCleansing Notice30/01/13
UCMAppendix 3B25/01/13
UCMReduction in Sepsis Deaths and Hospital Costs Using USCOMPRICE SENSITIVE22/01/13
UCMAppendix 4C - quarterlyPRICE SENSITIVE22/01/13
UCMUscom Presentation27/11/12
UCMChange of Director's Interest Notice08/11/12
UCMChange of Director's Interest Notice08/11/12
UCMCleansing Notice08/11/12
UCMAppendix 3B08/11/12
UCMResults of Meeting07/11/12
UCM2012 AGM Presentation07/11/12
UCMUSCOM more accurate monitor than blood pressure in pregnancyPRICE SENSITIVE23/10/12
UCMAppendix 4C Commentary17/10/12
UCM Uscom Earnings Call
19/02/15
UCM Appendix 4C - quarterly
29/01/15PRICE SENSITIVE
UCM USCOM 1A - New Regulatory Registration for China
27/01/15PRICE SENSITIVE
UCM Distribution and Sales Manager Appointment
17/12/14
UCM Appendix 3B
03/12/14
UCM Change of Director's Interest Notice Appendix 3Y
27/11/14
UCM Appendix 3B
27/11/14
UCM Results of Meeting
26/11/14
UCM 2014 AGM Presentation
26/11/14
UCM Uscom - Johnson and Johnson Innovation Company of the Year
30/10/14
UCM USCOM Sale into Space Programme
27/10/14
UCM Notice of Annual General Meeting/Proxy Form
24/10/14
UCM Appendix 4C - quarterly
21/10/14PRICE SENSITIVE
UCM Appendix 3B
09/10/14
UCM Appendix 3B
01/10/14
UCM Date of AGM
29/09/14
UCM Uscom Finalist in NSW Premiers Export Awards
17/09/14
UCM USCOM Part of World Sepsis Day in London
12/09/14
UCM Uscom Presentation
09/09/14
UCM New USCOM science in critical applications
04/09/14PRICE SENSITIVE
UCM TGA Approval for Uscom BP Central Blood Pressure
25/08/14PRICE SENSITIVE
UCM Preliminary and Annual Report to shareholders
18/08/14PRICE SENSITIVE
UCM Appendix 4C - quarterly
28/07/14PRICE SENSITIVE
UCM Uscom Manufactures First Australian BPplus Device
23/06/14PRICE SENSITIVE
UCM Release of securities from voluntary escrow
20/06/14
UCM Uscom appoints new US distributor for USCOM 1A monitor
16/06/14PRICE SENSITIVE
UCM Change in substantial holding
10/06/14
UCMChange in substantial holding
29/05/14
UCMChange in substantial holding
23/05/14
UCMAppendix 3B
20/05/14
UCMUscom Limited Securities Issued Under Listing Rule 7.1A
20/05/14
UCMCleansing Statement - Private Placement
20/05/14
UCMUscom appoints three new UK distributors for BP monitor
19/05/14PRICE SENSITIVE
UCMUscom Announces Successful Capital Raising
15/05/14PRICE SENSITIVE
UCMTrading Halt
13/05/14PRICE SENSITIVE
UCMUscom receives new US Patent notification for BP monitor
12/05/14PRICE SENSITIVE
UCMAppendix 4C - quarterly
28/04/14PRICE SENSITIVE
UCMInvestment overview
27/03/14
UCMUscom appoints new Scandinavian distributor
10/03/14
UCMUscom appoints new German distributor
03/03/14
UCMChange of Director's Interest Notice
28/02/14
UCMAppendix 3B
28/02/14
UCMUscom appoints new European distributor
27/02/14PRICE SENSITIVE
UCMUscom BP new hypertension gold standard in children
24/02/14PRICE SENSITIVE
UCMHalf Yearly Report and Accounts
21/02/14PRICE SENSITIVE
UCMUscom Presentation
20/02/14
UCMUscom BP leading blood pressure technology - Global study
10/02/14PRICE SENSITIVE
UCMUscom BP receives CE Mark for sales into Europe
04/02/14PRICE SENSITIVE
UCMUscom appoints Deltex to distribution team
29/01/14PRICE SENSITIVE
UCMAppendix 4C - quarterly
29/01/14PRICE SENSITIVE
UCMChange in substantial holding
20/12/13
UCMChange of Director's Interest Notice
14/11/13
UCMCleansing Notice
14/11/13
UCMAppendix 3B
14/11/13
UCMResults of Meeting
13/11/13
UCM2013 AGM Presentation
13/11/13
UCMNew US USCOM Distribution Agreement
12/11/13
UCMAppendix 4C - quarterly
28/10/13PRICE SENSITIVE
UCMUscom signs 5 year $7m China sales deal
15/10/13PRICE SENSITIVE
UCMNotice of Annual General Meeting/Proxy Form
11/10/13
UCMUscom - New Global Sales Manager Appointed
24/09/13
UCMAppendix 3B
18/09/13
UCMSecurities Issued Under Listing Rule 7.1A
18/09/13
UCMCleansing Notice
18/09/13
UCMSuccessful capital raising to support new sales initiatives
18/09/13PRICE SENSITIVE
UCMPreliminary and Annual Report to shareholders
30/08/13PRICE SENSITIVE
UCMUscom Presentation - Amended
07/08/13
UCMUscom Presentation
07/08/13
UCMCleansing Notice
06/08/13
UCMAppendix 3B
06/08/13
UCMAppendix 4C - quarterly
26/07/13PRICE SENSITIVE
UCMCompany Secretary Appointment/Resignation
18/07/13
UCMUSCOM - New Paediatric Publications in Sepsis and Emergency
03/07/13
UCMUscom Announces Italian Distribution Deal with Vega
25/06/13PRICE SENSITIVE
UCMCleansing Notice
20/06/13
UCMUscom Completes Pulsecor Asset Purchase - Amended Date
18/06/13
UCMUscom Completes Pulsecor Asset Purchase
18/06/13PRICE SENSITIVE
UCMAppendix 3B
17/06/13
UCMUscom Presentation - Amended
17/06/13
UCMUscom Presentation
14/06/13
UCMUscom to Acquire Pulsecor and New Blood Pressure Products
30/05/13PRICE SENSITIVE
UCMChange of Director's Interest Notice
16/05/13
UCMNew USCOM Method for Measurement of Heart Function
08/05/13PRICE SENSITIVE
UCMUSCOM Strategic Focus - New Distribution in Mexico
01/05/13PRICE SENSITIVE
UCMAppendix 4C - quarterly
26/04/13PRICE SENSITIVE
UCMChange of Director's Interest Notice
19/03/13
UCMHalf Yearly Report and Accounts
27/02/13PRICE SENSITIVE
UCMCleansing Notice
30/01/13
UCMAppendix 3B
25/01/13
UCMReduction in Sepsis Deaths and Hospital Costs Using USCOM
22/01/13PRICE SENSITIVE
UCMAppendix 4C - quarterly
22/01/13PRICE SENSITIVE
UCMUscom Presentation
27/11/12
UCMChange of Director's Interest Notice
08/11/12
UCMChange of Director's Interest Notice
08/11/12
UCMCleansing Notice
08/11/12
UCMAppendix 3B
08/11/12
UCMResults of Meeting
07/11/12
UCM2012 AGM Presentation
07/11/12
UCMUSCOM more accurate monitor than blood pressure in pregnancy
23/10/12PRICE SENSITIVE
UCMAppendix 4C Commentary
17/10/12
(20min delay)
Last
3.2¢
Change
0.000(0.00%)
Mkt cap ! $3.506M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 150000 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 200000 1
View Market Depth
Last trade - 16.12pm 29/11/2024 (20 minute delay) ?
UCM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.